EV
Eric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $7.3M of ROIV (200,000 sh × $36.62, as filed), executed Sep 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$87.9M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $181.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
17 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$7.3M200,000 sh × $36.31
Exec Nov 3
Filed Nov 5 · 6:11 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $7.3M
200,000 sh × $36.59
Exec Oct 28
Filed Oct 30 · 6:29 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $7.0M
200,000 sh across 2 lots
Exec Oct 20
Filed Oct 22 · 6:44 PM ET IMVTSALE Immunovant, Inc. View filing → $120K
3,506 sh × $34.11
Exec Oct 2
Filed Oct 5 · 7:42 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $7.3M
200,000 sh × $36.62
Exec Sep 30
Filed Oct 2 · 5:37 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $7.2M
200,000 sh across 2 lots
Exec Aug 28
Filed Sep 1 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $7.0M
200,000 sh × $34.95
Exec Jul 27
Filed Jul 29 · 9:00 PM ET IMVTSALE Immunovant, Inc. View filing → $119K
3,092 sh × $38.48
Exec Jul 2
Filed Jul 6 · 5:01 PM ET More filings →